Zurich Cantonal Bank
FATE icon

Zurich Cantonal Bank’s Fate Therapeutics FATE Stock Holding History

Zurich Cantonal Bank’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,660
Closed -$31.1K – 2754
2023
Q3 		$31.1K Hold
14,660
– – ﹤0.01% 2675
2023
Q2 		$69.8K Hold
14,660
– – ﹤0.01% 2504
2023
Q1 		$83.6K Hold
14,660
– – ﹤0.01% 2384
2022
Q4 		$148K Buy
14,660
+4,685
+47% +$88K ﹤0.01% 2014
2022
Q3 		$224K Hold
9,975
– – ﹤0.01% 1682
2022
Q2 		$247K Hold
9,975
– – ﹤0.01% 1674
2022
Q1 		$387K Sell
9,975
-3,385
-25% -$131K ﹤0.01% 1487
2021
Q4 		$782K Buy
13,360
+5,135
+62% +$291K ﹤0.01% 1144
2021
Q3 		$487K Sell
8,225
-13
-0.2% -$1.02K ﹤0.01% 1317
2021
Q2 		$715K Buy
8,238
+32
+0.4% +$2.58K ﹤0.01% 1023
2021
Q1 		$677K Sell
8,206
-1,291
-14% -$124K ﹤0.01% 1039
2020
Q4 		$864K Buy
9,497
+2,573
+37% +$160K 0.01% 1008
2020
Q3 		$277K Hold
6,924
– – ﹤0.01% 1381
2020
Q2 		$238K Buy
6,924
+1,745
+34% +$52K ﹤0.01% 1414
2020
Q1 		$115K Buy
5,179
+2,245
+77% +$56.8K ﹤0.01% 1528
2019
Q4 		$57K Hold
2,934
– – ﹤0.01% 2071
2019
Q3 		$46K Hold
2,934
– – ﹤0.01% 2095
2019
Q2 		$60K Hold
2,934
– – ﹤0.01% 1942
2019
Q1 		$52K Sell
2,934
-931
-24% -$14.7K ﹤0.01% 1976
2018
Q4 		$50K Buy
3,865
+1,464
+61% +$20.4K ﹤0.01% 2027
2018
Q3 		$39K Buy
+2,401
New +$28.4K ﹤0.01% 2278

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Zurich Cantonal Bank's FATE Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of Fate Therapeutics (FATE) in Q4 2023, closing a stake of 14,660 shares — an estimated $31.1K sold.

Zurich Cantonal Bank first reported a position in FATE in Q3 2018 and held it in 21 quarters. The position peaked at $864K in Q4 2020. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2023.

  • Zurich Cantonal Bank reported no remaining Fate Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 14,660 Fate Therapeutics shares in Q4 2023, an estimated $31.1K.
  • Zurich Cantonal Bank first reported a position in Fate Therapeutics in Q3 2018 and held it in 21 quarters.
  • Zurich Cantonal Bank's Fate Therapeutics position peaked at $864K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.